rxstat › Shortages › Almotriptan

Almotriptan shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Almotriptan products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 23, 2026.
Products affected
1 of 10
In shortage since
Jan 16, 2026
Est. full return
Jan 23, 2026
Reports on file
23
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
MYLAN-ALMOTRIPTAN
12.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02398443 · since Jan 16, 2026, est. end Jan 23, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ALMOTRIPTAN
12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02405334 · ended May 4, 2026 · Disruption of the manufacture of the drug.
Discontinued
TEVA-ALMOTRIPTAN
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02434849
Resolved
TEVA-ALMOTRIPTAN
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02434849 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-ALMOTRIPTAN
6.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02398435 · ended Mar 22, 2024 · Shortage of an active ingredient.
Resolved
MYLAN-ALMOTRIPTAN
12.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02398443 · ended Mar 20, 2024 · Shortage of an active ingredient.
Resolved
TEVA-ALMOTRIPTAN
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02434849 · ended Jun 20, 2023 · Disruption of the manufacture of the drug.
Resolved
MYLAN-ALMOTRIPTAN
12.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02398443 · ended Mar 22, 2022 · Shortage of an active ingredient.
Resolved
MYLAN-ALMOTRIPTAN
6.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02398435 · ended Mar 22, 2022 · Shortage of an active ingredient.
Resolved
ALMOTRIPTAN
12.5MG · TABLET · SANIS HEALTH INC
DIN 02466821 · ended Sep 6, 2019 · Disruption of the manufacture of the drug.
Resolved
TEVA-ALMOTRIPTAN
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02434849 · ended Aug 28, 2019 · Requirements related to complying with good manufacturing practices.
Resolved
APO-ALMOTRIPTAN
12.5MG · TABLET · APOTEX INC
DIN 02405806 · ended May 13, 2019 · Disruption of the manufacture of the drug.

Showing 12 of 23 reports. All reports are on file with Health Canada.

What's happening

Almotriptan is currently affected by an active shortage report filed with Health Canada by MYLAN PHARMACEUTICALS ULC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Almotriptan is classified under “ANTIMIGRAINE PREPARATIONS” (ATC N02CC).

Recent changes

Common questions

When will Almotriptan be back in stock in Canada?

The latest manufacturer estimate is Jan 23, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Almotriptan in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antimigraine preparations)

Partial shortageEletriptan1 of 18 reported products affected · est. return Jul 28, 2026Partial shortagePizotifen1 of 1 reported products affected · est. return Jul 31, 2026Partial shortageRizatriptan9 of 37 reported products affected · est. return Dec 31, 2026Partial shortageZolmitriptan11 of 28 reported products affected · est. return Jan 3, 2028No current shortageDihydroergotamineNo current shortageFrovatriptan

All antimigraine preparations shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.